Back to Trades
Other4
BRISTOL MYERS SQUIBB CO
BMY
Total Value
$83.6K
Company Information
- Company Name
- BRISTOL MYERS SQUIBB CO
- Ticker Symbol
- BMY
- CIK
- 0000014272
Insider Information
- Name
- Hoch Lynelle
- Role
- President, Cell Therapy Org.
- Location
- PRINCETON, NJ
Officer
Filing Details
- Filing Date
- Mar 12, 2026
- Transaction Date
- Mar 10, 2026
- Accession Number
- 0002005382-26-000002
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Mar 10, 2026 | Common Stock, $0.10 par value | 838 | — | Exercise | — |
| Mar 10, 2026 | Common Stock, $0.10 par value | 94 | — | Other | — |
| Mar 10, 2026 | Common Stock, $0.10 par value | 212 | $60.13 | Tax Withholding | $12.7K |
| Mar 10, 2026 | Common Stock, $0.10 par value | 1,050 | — | Exercise | — |
| Mar 10, 2026 | Common Stock, $0.10 par value | 113 | — | Other | — |
| Mar 10, 2026 | Common Stock, $0.10 par value | 267 | $60.13 | Tax Withholding | $16.1K |
| Mar 10, 2026 | Common Stock, $0.10 par value | 6,304 | — | Exercise | — |
| Mar 10, 2026 | Common Stock, $0.10 par value | 3,095 | — | Other | — |
| Mar 10, 2026 | Common Stock, $0.10 par value | 912 | $60.13 | Tax Withholding | $54.8K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Mar 10, 2026 | Derivative | 838 | — | Exercise | — |
| Mar 10, 2026 | Derivative | 1,050 | — | Exercise | — |
| Mar 10, 2026 | Derivative | 6,304 | — | Exercise | — |
| Mar 10, 2026 | Derivative | 6,531 | — | Grant/Award | — |
| Mar 10, 2026 | Derivative | 9,796 | — | Grant/Award | — |
Footnotes
- (F1)Represents vesting of one-quarter of market share units granted on March 10, 2022.
- (F2)Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor.
- (F3)Shares withheld for payment of taxes upon vesting of awards.
- (F4)Represents vesting of one-quarter of market share units granted on March 10, 2023.
- (F5)Amount represents distribution of performance shares earned under the 2023-2025 Long-Term Performance Award.
- (F6)Adjustment to award based on the performance factor applied in accordance with the terms of the award and certification of performance results by the Board.
- (F7)Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%.
- (F8)Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2026.
- (F9)Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is the greater of Total Return and relative total shareholder return (rTSR) Floor. Total Return is a ratio of the 10-day average closing stock price on the measurement date, plus the value of accumulated dividends, divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor for Total Return performance that must be achieved to earn a payout is 80% and the maximum is 225%. The rTSR Floor feature provides a minimum level of payout if BMS stock price declines from the grant date but outperforms our peers based on their TSR percentile rank. A TSR percentile rank (i) below the 50th percentile yields a 0% payout, (ii) between the 50th and 74.99th percentiles yields a 50% payout, and (iii) at or above the 75th percentile yields a 100% payout.
- (F10)These market share units cliff vest on the third anniversary of the grant date, subject to certification of performance results by the Board.
- (F11)Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2029, subject to certification of performance results by the Board.